Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Auranofin in CLL/SLL/PLL
NCT01419691Phase 2Completed
- Sponsor
- University of Kansas Medical Center
- Start
- Sep 2011
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of auranofin in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), prolymphocytic leukemia (PLL), sponsored by University of Kansas Medical Center. Started Sep 2011; status: completed.
02
Drugs
auranofin
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)prolymphocytic leukemia (PLL)
Beyond the preview
Go deeper on NCT01419691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01419691.